Sign Up Today and Learn More About NEUROPHET Stock
Invest in or calculate the value of your shares in NEUROPHET or other pre-IPO companies through EquityZen's platform.
NEUROPHET Stock (NEPH)
NEUROPHET Inc. is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.
About NEUROPHET Stock
Founded
2016
Industries
Software, Artificial Intelligence, Data and Analytics
NEUROPHET Press Mentions
Stay in the know about the latest news on NEUROPHET
Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD'
morningstar • Jun 13, 2025
Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD'
en • Jun 13, 2025
Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD'
prnewswire • Jun 13, 2025
Neurophet Presented Three Research Abstracts on Personalized tDCS at International Brain Stimulation Conference
prnewswire • Feb 26, 2025
Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth
en • Dec 04, 2024
NEUROPHET Management
Leadership team at NEUROPHET
Co-founder/CTO
Donghyeon Kim
Co-founder / CEO
Junkil Been
Join now and verify your accreditation status to gain access to:
- NEUROPHET Current Valuation
- NEUROPHET Stock Price
- NEUROPHET Management
- Available deals in NEUROPHET and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- NEUROPHET Cap Table and Funding History by Share Class and Liquidity Preferences
- NEUROPHET Revenue and Financials
- NEUROPHET Highlights
- NEUROPHET Business Model
- NEUROPHET Risk Factors
- NEUROPHET Research Report from SACRA Research
Trading NEUROPHET Stock
How to invest in NEUROPHET stock?
Accredited investors can buy pre-IPO stock in companies like NEUROPHET through EquityZen funds. These investments are made available by existing NEUROPHET shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NEUROPHET stock?
Shareholders can sell their NEUROPHET stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
